ADMA Biologics Inc — Quarterly Financial Statistics (NASDAQ:ADMA) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities 50.22 M-19.68 M21.14 M13.29 M35.64 M 50.4 M Cash from investing activities -2.75 M-4.72 M-2.53 M-14.37 M-276 K -21.89 M Cash from financing activities -31.03 M-7.13 M48 K-27.82 M-9.12 M -44.02 M Free cash flow 50.22 M-19.68 M21.14 M13.29 M35.64 M 50.4 M

Nouvelles

NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program

Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider

ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?